25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

China Pharma Holdings Inc
Buy, Hold or Sell?

Let's analyze China Pharma Holdings Inc together

I guess you are interested in China Pharma Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of China Pharma Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about China Pharma Holdings Inc

I send you an email if I find something interesting about China Pharma Holdings Inc.

1. Quick Overview

1.1. Quick analysis of China Pharma Holdings Inc (30 sec.)










1.2. What can you expect buying and holding a share of China Pharma Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.34
Expected worth in 1 year
$0.36
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$0.02
Return On Investment
12.5%

For what price can you sell your share?

Current Price per Share
$0.17
Expected price per share
$0.0892 - $0.2035
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of China Pharma Holdings Inc (5 min.)




Live pricePrice per Share (EOD)
$0.17
Intrinsic Value Per Share
$-0.25 - $2.55
Total Value Per Share
$0.09 - $2.89

2.2. Growth of China Pharma Holdings Inc (5 min.)




Is China Pharma Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$6.5m$4.8m$2.5m34.6%

How much money is China Pharma Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.1m-$1.1m-$8.2k-0.7%
Net Profit Margin-96.0%-61.2%--

How much money comes from the company's main activities?

2.3. Financial Health of China Pharma Holdings Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of China Pharma Holdings Inc?

Welcome investor! China Pharma Holdings Inc's management wants to use your money to grow the business. In return you get a share of China Pharma Holdings Inc.

First you should know what it really means to hold a share of China Pharma Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of China Pharma Holdings Inc is $0.174. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of China Pharma Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in China Pharma Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.34. Based on the TTM, the Book Value Change Per Share is $0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of China Pharma Holdings Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-33.4%-0.06-35.4%-0.06-35.2%-0.10-55.5%-0.14-80.8%
Usd Book Value Change Per Share-0.05-26.3%0.013.1%0.0424.4%-0.05-31.1%-0.14-80.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-26.3%0.013.1%0.0424.4%-0.05-31.1%-0.14-80.7%
Usd Price Per Share0.24-0.24-0.24-0.38-0.31-
Price to Earnings Ratio-1.02--1.05--1.24-10.52-4.83-
Price-to-Total Gains Ratio-5.17--0.08-0.49-34.04-15.77-
Price to Book Ratio0.70-0.63-1.00-1.12-0.61-
Price-to-Total Gains Ratio-5.17--0.08-0.49-34.04-15.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.174
Number of shares5747
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.01-0.05
Usd Total Gains Per Share0.01-0.05
Gains per Quarter (5747 shares)31.15-310.86
Gains per Year (5747 shares)124.58-1,243.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101251150-1243-1253
202492400-2487-2496
303743650-3730-3739
404984900-4974-4982
506236150-6217-6225
607477400-7461-7468
708728650-8704-8711
809979900-9947-9954
90112111150-11191-11197
100124612400-12434-12440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%3.037.00.07.5%32.061.00.034.4%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%8.012.00.040.0%10.030.00.025.0%42.048.03.045.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%2.00.091.02.2%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%8.012.00.040.0%10.030.00.025.0%42.048.03.045.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of China Pharma Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0460.005-944%0.043-207%-0.054+18%-0.140+207%
Book Value Per Share--0.3390.385-12%0.252+34%0.337+1%1.665-80%
Current Ratio--0.7850.851-8%0.581+35%0.627+25%1.174-33%
Debt To Asset Ratio--0.5150.508+1%0.704-27%0.648-20%0.457+13%
Debt To Equity Ratio--1.0631.037+2%2.496-57%2.083-49%1.225-13%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value---1669091.580-2395488.885+44%-5633358.250+238%-3518421.122+111%-7685449.549+360%
Eps---0.058-0.062+6%-0.061+5%-0.097+66%-0.141+142%
Ev To Ebitda Ratio--1.079inf+inf%-0.309+129%inf+inf%inf+inf%
Ev To Sales Ratio---0.379-0.374-1%-0.729+92%-0.454+20%-0.646+70%
Free Cash Flow Per Share---0.002-0.010+397%-0.002+23%-0.012+536%0.004-150%
Free Cash Flow To Equity Per Share---0.002-0.009+466%-0.011+560%-0.003+104%-0.006+262%
Gross Profit Margin--1.1201.078+4%1.224-8%-1.564+240%-0.128+111%
Intrinsic Value_10Y_max--2.552--------
Intrinsic Value_10Y_min---0.248--------
Intrinsic Value_1Y_max--0.051--------
Intrinsic Value_1Y_min---0.041--------
Intrinsic Value_3Y_max--0.308--------
Intrinsic Value_3Y_min---0.111--------
Intrinsic Value_5Y_max--0.755--------
Intrinsic Value_5Y_min---0.165--------
Market Cap3350091.600-36%4549578.4204702161.615-3%4693016.250-3%7228111.428-37%6117799.576-26%
Net Profit Margin---1.016-0.960-5%-0.612-40%-1.009-1%-0.990-3%
Operating Margin---0.985-0.789-20%-0.316-68%-0.258-74%-0.280-72%
Operating Ratio--1.9862.186-9%1.357+46%0.877+126%0.362+449%
Pb Ratio0.513-36%0.6970.629+11%1.003-31%1.125-38%0.614+14%
Pe Ratio-0.749+26%-1.017-1.048+3%-1.242+22%10.520-110%4.830-121%
Price Per Share0.174-36%0.2360.244-3%0.244-3%0.375-37%0.312-24%
Price To Free Cash Flow Ratio-22.197+26%-30.144-16.688-45%-1.787-94%-6.691-78%-3.269-89%
Price To Total Gains Ratio-3.806+26%-5.168-0.080-98%0.487-1161%34.039-115%15.770-133%
Quick Ratio--0.2420.191+26%0.185+31%0.205+18%0.496-51%
Return On Assets---0.083-0.079-4%-0.070-16%-0.112+35%-0.082-1%
Return On Equity---0.171-0.161-6%-0.251+47%-0.342+100%-0.207+21%
Total Gains Per Share---0.0460.005-944%0.043-207%-0.054+18%-0.140+207%
Usd Book Value--6528249.0007420886.500-12%4855713.000+34%6487431.550+1%32653367.500-80%
Usd Book Value Change Per Share---0.0460.005-944%0.043-207%-0.054+18%-0.140+207%
Usd Book Value Per Share--0.3390.385-12%0.252+34%0.337+1%1.665-80%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value---1669091.580-2395488.885+44%-5633358.250+238%-3518421.122+111%-7685449.549+360%
Usd Eps---0.058-0.062+6%-0.061+5%-0.097+66%-0.141+142%
Usd Free Cash Flow---37732.000-187638.000+397%-46554.750+23%-240161.600+536%88015.900-143%
Usd Free Cash Flow Per Share---0.002-0.010+397%-0.002+23%-0.012+536%0.004-150%
Usd Free Cash Flow To Equity Per Share---0.002-0.009+466%-0.011+560%-0.003+104%-0.006+262%
Usd Market Cap3350091.600-36%4549578.4204702161.615-3%4693016.250-3%7228111.428-37%6117799.576-26%
Usd Price Per Share0.174-36%0.2360.244-3%0.244-3%0.375-37%0.312-24%
Usd Profit---1117911.000-1186036.500+6%-1177815.500+5%-2202033.150+97%-2893823.125+159%
Usd Revenue--1100152.0001386155.000-21%1945653.250-43%2103355.500-48%2874276.725-62%
Usd Total Gains Per Share---0.0460.005-944%0.043-207%-0.054+18%-0.140+207%
 EOD+3 -5MRQTTM+16 -22YOY+23 -155Y+30 -810Y+19 -19

3.3 Fundamental Score

Let's check the fundamental score of China Pharma Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.749
Price to Book Ratio (EOD)Between0-10.513
Net Profit Margin (MRQ)Greater than0-1.016
Operating Margin (MRQ)Greater than0-0.985
Quick Ratio (MRQ)Greater than10.242
Current Ratio (MRQ)Greater than10.785
Debt to Asset Ratio (MRQ)Less than10.515
Debt to Equity Ratio (MRQ)Less than11.063
Return on Equity (MRQ)Greater than0.15-0.171
Return on Assets (MRQ)Greater than0.05-0.083
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of China Pharma Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.535
Ma 20Greater thanMa 500.191
Ma 50Greater thanMa 1000.213
Ma 100Greater thanMa 2000.212
OpenGreater thanClose0.174
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About China Pharma Holdings Inc

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-12-15 05:12:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit China Pharma Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare China Pharma Holdings Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -101.6% means that $-1.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of China Pharma Holdings Inc:

  • The MRQ is -101.6%. The company is making a huge loss. -2
  • The TTM is -96.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-101.6%TTM-96.0%-5.6%
TTM-96.0%YOY-61.2%-34.8%
TTM-96.0%5Y-100.9%+4.9%
5Y-100.9%10Y-99.0%-1.9%
4.3.1.2. Return on Assets

Shows how efficient China Pharma Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare China Pharma Holdings Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -8.3% Return on Assets means that China Pharma Holdings Inc generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of China Pharma Holdings Inc:

  • The MRQ is -8.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.3%TTM-7.9%-0.4%
TTM-7.9%YOY-7.0%-1.0%
TTM-7.9%5Y-11.2%+3.3%
5Y-11.2%10Y-8.2%-3.0%
4.3.1.3. Return on Equity

Shows how efficient China Pharma Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare China Pharma Holdings Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -17.1% Return on Equity means China Pharma Holdings Inc generated $-0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of China Pharma Holdings Inc:

  • The MRQ is -17.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.1%TTM-16.1%-1.0%
TTM-16.1%YOY-25.1%+9.0%
TTM-16.1%5Y-34.2%+18.0%
5Y-34.2%10Y-20.7%-13.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of China Pharma Holdings Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient China Pharma Holdings Inc is operating .

  • Measures how much profit China Pharma Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare China Pharma Holdings Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -98.5% means the company generated $-0.99  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of China Pharma Holdings Inc:

  • The MRQ is -98.5%. The company is operating very inefficient. -2
  • The TTM is -78.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-98.5%TTM-78.9%-19.6%
TTM-78.9%YOY-31.6%-47.3%
TTM-78.9%5Y-25.8%-53.1%
5Y-25.8%10Y-28.0%+2.2%
4.3.2.2. Operating Ratio

Measures how efficient China Pharma Holdings Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.99 means that the operating costs are $1.99 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of China Pharma Holdings Inc:

  • The MRQ is 1.986. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.186. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.986TTM2.186-0.200
TTM2.186YOY1.357+0.829
TTM2.1865Y0.877+1.309
5Y0.87710Y0.362+0.515
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of China Pharma Holdings Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if China Pharma Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.79 means the company has $0.79 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of China Pharma Holdings Inc:

  • The MRQ is 0.785. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.851. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.785TTM0.851-0.065
TTM0.851YOY0.581+0.269
TTM0.8515Y0.627+0.223
5Y0.62710Y1.174-0.547
4.4.3.2. Quick Ratio

Measures if China Pharma Holdings Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare China Pharma Holdings Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.24 means the company can pay off $0.24 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of China Pharma Holdings Inc:

  • The MRQ is 0.242. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.191. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.242TTM0.191+0.051
TTM0.191YOY0.185+0.006
TTM0.1915Y0.205-0.014
5Y0.20510Y0.496-0.290
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of China Pharma Holdings Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of China Pharma Holdings Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare China Pharma Holdings Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.52 means that China Pharma Holdings Inc assets are financed with 51.5% credit (debt) and the remaining percentage (100% - 51.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of China Pharma Holdings Inc:

  • The MRQ is 0.515. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.508. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.515TTM0.508+0.007
TTM0.508YOY0.704-0.196
TTM0.5085Y0.648-0.140
5Y0.64810Y0.457+0.190
4.5.4.2. Debt to Equity Ratio

Measures if China Pharma Holdings Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare China Pharma Holdings Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 106.3% means that company has $1.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of China Pharma Holdings Inc:

  • The MRQ is 1.063. The company is able to pay all its debts with equity. +1
  • The TTM is 1.037. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.063TTM1.037+0.025
TTM1.037YOY2.496-1.458
TTM1.0375Y2.083-1.045
5Y2.08310Y1.225+0.857
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings China Pharma Holdings Inc generates.

  • Above 15 is considered overpriced but always compare China Pharma Holdings Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.02 means the investor is paying $-1.02 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of China Pharma Holdings Inc:

  • The EOD is -0.749. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.017. Based on the earnings, the company is expensive. -2
  • The TTM is -1.048. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.749MRQ-1.017+0.268
MRQ-1.017TTM-1.048+0.030
TTM-1.048YOY-1.242+0.195
TTM-1.0485Y10.520-11.568
5Y10.52010Y4.830+5.691
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of China Pharma Holdings Inc:

  • The EOD is -22.197. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -30.144. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -16.688. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-22.197MRQ-30.144+7.947
MRQ-30.144TTM-16.688-13.456
TTM-16.688YOY-1.787-14.901
TTM-16.6885Y-6.691-9.997
5Y-6.69110Y-3.269-3.422
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of China Pharma Holdings Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of China Pharma Holdings Inc:

  • The EOD is 0.513. Based on the equity, the company is cheap. +2
  • The MRQ is 0.697. Based on the equity, the company is cheap. +2
  • The TTM is 0.629. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.513MRQ0.697-0.184
MRQ0.697TTM0.629+0.068
TTM0.629YOY1.003-0.374
TTM0.6295Y1.125-0.496
5Y1.12510Y0.614+0.511
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of China Pharma Holdings Inc.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets13,466
Total Liabilities6,937
Total Stockholder Equity6,528
 As reported
Total Liabilities 6,937
Total Stockholder Equity+ 6,528
Total Assets = 13,466

Assets

Total Assets13,466
Total Current Assets3,739
Long-term Assets9,727
Total Current Assets
Cash And Cash Equivalents 719
Short-term Investments 27
Net Receivables 407
Inventory 2,499
Other Current Assets 115
Total Current Assets  (as reported)3,739
Total Current Assets  (calculated)3,766
+/- 27
Long-term Assets
Property Plant Equipment 4,963
Goodwill 402
Intangible Assets 4,764
Long-term Assets Other 718,690,281
Long-term Assets  (as reported)9,727
Long-term Assets  (calculated)718,700,410
+/- 718,690,683

Liabilities & Shareholders' Equity

Total Current Liabilities4,760
Long-term Liabilities2,177
Total Stockholder Equity6,528
Total Current Liabilities
Short-term Debt 2,584
Accounts payable 390
Other Current Liabilities 1,362
Total Current Liabilities  (as reported)4,760
Total Current Liabilities  (calculated)4,336
+/- 424
Long-term Liabilities
Long-term Liabilities  (as reported)2,177
Long-term Liabilities  (calculated)0
+/- 2,177
Total Stockholder Equity
Common Stock18
Retained Earnings -42,802
Accumulated Other Comprehensive Income 11,523
Other Stockholders Equity 37,790
Total Stockholder Equity (as reported)6,528
Total Stockholder Equity (calculated)6,528
+/-0
Other
Cash and Short Term Investments 719
Common Stock Shares Outstanding 17,307
Current Deferred Revenue25
Liabilities and Stockholders Equity 13,466
Net Debt 3,292
Net Working Capital -1,021
Short Long Term Debt Total 4,011



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-30
> Total Assets 
588
582
833
426
426
374
341
299
299
0
4
0
0
0
0
0
17,978
0
20,282
21,553
25,516
28,514
35,294
39,194
42,884
43,706
50,490
65,112
66,825
75,472
80,426
85,929
95,309
100,941
108,153
115,865
121,541
131,751
137,223
143,439
149,119
156,391
163,624
164,886
166,047
163,240
159,260
158,933
162,487
157,611
154,345
146,030
140,533
132,082
125,164
121,236
112,683
97,222
97,032
91,977
87,408
78,520
78,143
77,125
74,995
59,953
59,953
58,308
52,535
45,377
45,241
43,030
39,901
22,235
22,436
23,165
21,125
21,118
19,848
19,944
18,183
22,650
21,043
17,918
16,204
17,784
17,356
15,704
15,352
16,469
16,190
14,261
13,466
13,46614,26116,19016,46915,35215,70417,35617,78416,20417,91821,04322,65018,18319,94419,84821,11821,12523,16522,43622,23539,90143,03045,24145,37752,53558,30859,95359,95374,99577,12578,14378,52087,40891,97797,03297,222112,683121,236125,164132,082140,533146,030154,345157,611162,487158,933159,260163,240166,047164,886163,624156,391149,119143,439137,223131,751121,541115,865108,153100,94195,30985,92980,42675,47266,82565,11250,49043,70642,88439,19435,29428,51425,51621,55320,282017,9780000040299299341374426426833582588
   > Total Current Assets 
5
21
44
4
4
28
30
4
4
0
4
0
0
0
0
0
15,325
0
17,282
18,563
22,549
25,707
32,557
36,494
38,180
38,830
42,342
56,439
54,518
59,732
62,953
64,372
70,014
71,303
76,408
81,993
85,229
91,934
96,618
100,976
106,171
110,609
117,120
118,174
118,702
112,531
108,219
101,123
98,274
83,956
77,876
69,010
63,599
54,493
48,109
44,348
39,858
24,957
25,117
23,817
20,990
17,520
17,461
17,209
14,997
12,290
12,290
13,077
9,710
8,747
8,221
7,688
6,239
5,579
6,361
7,258
5,034
5,322
4,883
5,263
4,141
9,093
8,165
6,259
5,606
5,965
6,081
5,527
5,807
5,997
5,124
3,973
3,739
3,7393,9735,1245,9975,8075,5276,0815,9655,6066,2598,1659,0934,1415,2634,8835,3225,0347,2586,3615,5796,2397,6888,2218,7479,71013,07712,29012,29014,99717,20917,46117,52020,99023,81725,11724,95739,85844,34848,10954,49363,59969,01077,87683,95698,274101,123108,219112,531118,702118,174117,120110,609106,171100,97696,61891,93485,22981,99376,40871,30370,01464,37262,95359,73254,51856,43942,34238,83038,18036,49432,55725,70722,54918,56317,282015,32500000404430284444215
       Cash And Cash Equivalents 
0
1
21
1
1
26
0
2
2
0
0
0
0
0
0
0
3,562
0
75
195
193
656
2,951
2,436
1,716
1,830
682
7,037
5,839
6,927
5,152
3,643
3,845
3,635
4,785
4,528
4,561
3,692
4,273
4,925
4,985
4,051
3,685
5,332
5,427
4,030
4,750
2,525
4,505
5,993
5,292
4,426
4,269
5,296
5,269
4,549
5,742
6,249
7,262
6,285
3,650
2,666
2,524
1,746
1,124
2,030
2,030
1,936
668
1,187
961
1,656
762
1,075
146
1,814
347
958
535
1,755
459
4,859
3,715
2,245
2,086
2,030
1,167
902
1,370
1,424
839
739
719
7197398391,4241,3709021,1672,0302,0862,2453,7154,8594591,7555359583471,8141461,0757621,6569611,1876681,9362,0302,0301,1241,7462,5242,6663,6506,2857,2626,2495,7424,5495,2695,2964,2694,4265,2925,9934,5052,5254,7504,0305,4275,3323,6854,0514,9854,9254,2733,6924,5614,5284,7853,6353,8453,6435,1526,9275,8397,0376821,8301,7162,4362,9516561931957503,562000000022026112110
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
469
237
132
84
365
460
365
102
1,181
1,714
281
336
64
93
116
458
121
91
313
0
116
1,261
1,492
1,089
1,734
2,586
1,404
750
1,210
319
0
0
0
0
0
0
0
0
0
0
0
0
0
91
14
11
45
14
35
80
0
0
66
15
27
271566008035144511149100000000000003191,2107501,4042,5861,7341,0891,4921,26111603139112145811693643362811,7141,1811023654603658413223746900000000000000000000000000000000000000
       Net Receivables 
0
17
21
3
3
2
30
2
2
2
4
0
0
0
0
0
6,965
0
8,934
9,606
11,792
12,458
15,591
17,245
17,845
19,069
25,282
28,165
31,860
36,172
41,257
42,945
51,002
53,115
55,392
54,974
56,925
62,013
64,130
66,227
68,780
69,751
73,622
71,443
69,948
66,358
64,134
57,626
53,339
45,659
42,606
36,481
31,275
25,582
19,177
17,667
12,511
6,173
5,100
4,527
4,427
4,224
3,990
3,387
3,108
2,496
2,496
2,575
971
1,108
1,122
971
883
728
956
693
665
583
614
473
494
835
472
385
537
464
691
447
397
504
391
284
407
4072843915043974476914645373854728354944736145836656939567288839711,1221,1089712,5752,4962,4963,1083,3873,9904,2244,4274,5275,1006,17312,51117,66719,17725,58231,27536,48142,60645,65953,33957,62664,13466,35869,94871,44373,62269,75168,78066,22764,13062,01356,92554,97455,39253,11551,00242,94541,25736,17231,86028,16525,28219,06917,84517,24515,59112,45811,7929,6068,93406,9650000042223023321170
       Other Current Assets 
4
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,723
1,979
2,012
2,315
2,538
4,421
4,903
3,482
1,568
6,261
2,276
3,032
2,753
2,332
252
320
392
3,184
3,882
5,841
5,100
5,846
5,785
84
4,872
4,346
4,834
5,784
6,075
7,262
7,792
7,627
7,084
7,142
9,040
8,293
8,314
8,508
9,315
2,872
2,839
4,066
4,343
3,319
3,961
4,818
3,936
226
1,357
2,189
1,972
1,398
1,204
669
621
187
1,634
898
509
76
72
57
114
59
72
99
96
565
604
436
302
0
215
116
115
1151162150302436604565969972591145772765098981,6341876216691,2041,3981,9722,1891,3572263,9364,8183,9613,3194,3434,0662,8392,8729,3158,5088,3148,2939,0407,1427,0847,6277,7927,2626,0755,7844,8344,3464,872845,7855,8465,1005,8413,8823,1843923202522,3322,7533,0322,2766,2611,5683,4824,9034,4212,5382,3152,0121,9791,723000000000000000124
   > Long-term Assets 
584
561
789
422
422
347
311
295
295
0
0
0
0
0
0
0
2,653
0
3,001
2,990
2,967
2,807
2,737
2,700
4,705
4,876
8,148
8,673
12,307
15,740
17,473
21,556
25,295
29,638
31,746
33,872
36,311
39,817
40,605
42,463
42,948
45,782
46,504
46,712
47,345
50,709
51,040
57,811
64,213
73,655
76,469
77,020
76,934
77,589
77,055
76,888
72,825
72,265
71,915
68,160
66,419
61,000
60,682
59,915
59,997
47,663
47,663
45,231
42,824
36,630
37,020
35,343
33,661
16,656
16,074
15,907
16,091
15,796
14,965
14,681
14,042
13,556
12,878
11,659
10,598
11,820
11,275
10,177
9,545
10,472
11,066
10,288
9,727
9,72710,28811,06610,4729,54510,17711,27511,82010,59811,65912,87813,55614,04214,68114,96515,79616,09115,90716,07416,65633,66135,34337,02036,63042,82445,23147,66347,66359,99759,91560,68261,00066,41968,16071,91572,26572,82576,88877,05577,58976,93477,02076,46973,65564,21357,81151,04050,70947,34546,71246,50445,78242,94842,46340,60539,81736,31133,87231,74629,63825,29521,55617,47315,74012,3078,6738,1484,8764,7052,7002,7372,8072,9672,9903,00102,6530000000295295311347422422789561584
       Property Plant Equipment 
482
461
442
422
422
347
311
295
295
0
0
0
0
0
0
0
2,538
0
2,758
2,806
2,772
2,725
2,661
2,630
2,622
2,625
2,636
2,604
2,620
6,738
7,159
6,756
6,872
6,706
6,538
6,409
6,395
6,372
6,230
6,266
6,210
6,335
6,171
6,022
5,818
8,585
8,839
14,948
20,136
29,780
33,058
33,658
33,412
33,423
32,773
32,134
30,011
28,959
28,390
26,791
25,917
24,562
24,014
23,665
23,723
23,541
23,108
21,159
19,646
18,885
18,860
17,632
16,456
16,047
15,483
15,324
15,494
15,182
14,364
14,080
13,453
12,967
12,295
11,117
10,094
9,608
9,039
8,103
7,510
6,819
6,548
5,895
4,963
4,9635,8956,5486,8197,5108,1039,0399,60810,09411,11712,29512,96713,45314,08014,36415,18215,49415,32415,48316,04716,45617,63218,86018,88519,64621,15923,10823,54123,72323,66524,01424,56225,91726,79128,39028,95930,01132,13432,77333,42333,41233,65833,05829,78020,13614,9488,8398,5855,8186,0226,1716,3356,2106,2666,2306,3726,3956,4096,5386,7066,8726,7567,1596,7382,6202,6042,6362,6252,6222,6302,6612,7252,7722,8062,75802,5380000000295295311347422422442461482
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
402
40200000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
93
91
214
0
0
0
0
0
0
0
0
0
0
0
0
0
62
0
87
77
70
65
59
53
2,065
2,063
2,515
5,693
2,432
6,163
10,314
14,801
18,422
22,932
20,948
23,390
26,342
29,049
29,698
30,788
30,331
3,083
2,950
2,799
2,644
2,860
2,739
2,649
2,532
2,173
2,058
1,964
1,868
1,776
1,687
1,617
1,477
1,275
1,216
1,114
1,044
940
897
869
859
832
832
753
699
676
670
636
610
609
591
583
597
614
600
601
589
590
582
542
504
2,212
2,236
2,074
2,035
3,653
4,518
4,394
4,764
4,7644,3944,5183,6532,0352,0742,2362,2125045425825905896016006145975835916096106366706766997538328328598698979401,0441,1141,2161,2751,4771,6171,6871,7761,8681,9642,0582,1732,5322,6492,7392,8602,6442,7992,9503,08330,33130,78829,69829,04926,34223,39020,94822,93218,42214,80110,3146,1632,4325,6932,5152,0632,06553596570778706200000000000002149193
       Long-term Assets Other 
9
8
133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,802
0
6,841
2,839
-585
-578
-252
-3,600
4,260
-467,274,000
3,574
35,421,253,000
4,677
5,409
6,134
9,417,488,000
37,384
37,891
38,882
11,444,748,000
39,462
40,213
-2,195,131,000
41,702
41,353
41,398
41,654
42,390
42,594
43,136
41,337
42,031
42,310
40,256
39,457
35,498
35,772
35,382
35,415
23,723
23,723
23,319
22,479
17,070
17,490
17,074
16,595
-16,656
-16,074
-15,907
-16,091
-15,796
-14,965
-14,681
-14,042
-13,556
-12,878
-11,659
-10,598
-11,820
-11,275
-10,177
0
0
-398
-395
718,690,281
718,690,281-395-39800-10,177-11,275-11,820-10,598-11,659-12,878-13,556-14,042-14,681-14,965-15,796-16,091-15,907-16,074-16,65616,59517,07417,49017,07022,47923,31923,72323,72335,41535,38235,77235,49839,45740,25642,31042,03141,33743,13642,59442,39041,65441,39841,35341,702-2,195,131,00040,21339,46211,444,748,00038,88237,89137,3849,417,488,0006,1345,4094,67735,421,253,0003,574-467,274,0004,260-3,600-252-578-5852,8396,84102,8020000000000000000000000013389
> Total Liabilities 
687
767
986
992
992
1,020
1,054
1,033
1,033
44
44
68
68
96
132
4
13,848
0
6,905
6,340
8,411
7,664
8,056
8,195
8,230
3,945
4,793
5,014
2,341
5,604
6,793
8,004
10,135
10,545
10,818
12,676
11,032
13,814
13,002
12,399
13,200
13,908
17,412
16,722
16,712
14,723
12,736
14,654
19,630
24,667
24,906
25,080
25,877
25,828
26,397
26,236
25,869
24,581
25,463
25,016
22,473
19,611
19,721
19,982
17,964
16,882
16,882
17,283
14,902
15,179
14,624
14,063
12,544
12,998
14,056
14,767
13,266
13,113
12,682
13,420
11,328
16,632
15,703
13,894
13,369
13,494
12,687
11,352
9,241
9,015
7,898
6,853
6,937
6,9376,8537,8989,0159,24111,35212,68713,49413,36913,89415,70316,63211,32813,42012,68213,11313,26614,76714,05612,99812,54414,06314,62415,17914,90217,28316,88216,88217,96419,98219,72119,61122,47325,01625,46324,58125,86926,23626,39725,82825,87725,08024,90624,66719,63014,65412,73614,72316,71216,72217,41213,90813,20012,39913,00213,81411,03212,67610,81810,54510,1358,0046,7935,6042,3415,0144,7933,9458,2308,1958,0567,6648,4116,3406,905013,848413296686844441,0331,0331,0541,020992992986767687
   > Total Current Liabilities 
204
276
433
673
673
971
1,006
906
906
44
44
68
68
96
132
4
13,817
0
6,874
6,309
8,379
7,632
8,024
8,162
8,197
3,911
4,758
4,978
2,305
5,567
6,757
7,967
10,098
10,508
10,818
12,676
11,032
12,808
12,673
12,326
13,200
13,779
17,268
16,565
16,541
14,627
12,625
14,518
12,955
12,006
11,729
11,869
14,269
14,172
14,666
14,446
16,126
12,791
14,061
14,101
12,951
10,398
10,540
10,480
10,385
9,227
9,227
9,712
9,767
10,051
9,249
8,983
9,609
10,045
11,172
11,340
11,554
11,404
11,030
12,195
10,453
10,513
9,903
8,361
12,628
12,739
11,922
10,547
7,058
6,821
5,728
4,712
4,760
4,7604,7125,7286,8217,05810,54711,92212,73912,6288,3619,90310,51310,45312,19511,03011,40411,55411,34011,17210,0459,6098,9839,24910,0519,7679,7129,2279,22710,38510,48010,54010,39812,95114,10114,06112,79116,12614,44614,66614,17214,26911,86911,72912,00612,95514,51812,62514,62716,54116,56517,26813,77913,20012,32612,67312,80811,03212,67610,81810,50810,0987,9676,7575,5672,3054,9784,7583,9118,1978,1628,0247,6328,3796,3096,874013,817413296686844449069061,006971673673433276204
       Short-term Debt 
166
203
259
444
444
712
748
639
639
0
0
0
0
0
0
0
6,304
0
4,241
4,256
6,452
6,534
6,598
6,699
6,794
2,693
2,421
2,474
0
2,480
2,483
2,484
3,803
3,803
3,803
3,819
2,986
3,781
3,817
3,868
3,913
3,932
3,957
3,959
3,956
4,761
4,787
4,860
4,889
4,910
4,869
4,874
6,500
6,516
6,548
6,569
7,869
6,163
6,204
7,275
5,218
2,529
3,159
3,897
3,673
2,305
3,015
3,741
3,661
3,455
3,154
2,776
2,699
2,351
2,398
3,636
4,103
6,524
6,365
7,598
7,473
7,194
6,944
5,818
10,114
8,757
8,651
7,712
3,942
0
2,736
2,654
2,584
2,5842,6542,73603,9427,7128,6518,75710,1145,8186,9447,1947,4737,5986,3656,5244,1033,6362,3982,3512,6992,7763,1543,4553,6613,7413,0152,3053,6733,8973,1592,5295,2187,2756,2046,1637,8696,5696,5486,5166,5004,8744,8694,9104,8894,8604,7874,7613,9563,9593,9573,9323,9133,8683,8173,7812,9863,8193,8033,8033,8032,4842,4832,48002,4742,4212,6936,7946,6996,5986,5346,4524,2564,24106,3040000000639639748712444444259203166
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,748
0
0
0
1,629
0
0
0
1,541
0
0
0
1,440
5,514
14,105
2,292
2,305
2,229
2,115
2,185
2,181
3,063
2,685
2,610
2,260
2,307
3,542
4,030
6,472
6,338
7,514
7,390
7,109
6,857
5,735
10,055
8,717
8,631
7,638
3,866
3,104
2,658
2,575
0
02,5752,6583,1043,8667,6388,6318,71710,0555,7356,8577,1097,3907,5146,3386,4724,0303,5422,3072,2602,6102,6853,0632,1812,1852,1152,2292,3052,29214,1055,5141,4400001,5410001,62900018,7480000000000000000000000000000000000000000000000000
       Accounts payable 
17
41
39
200
200
195
192
190
190
44
44
68
68
96
132
0
2,166
0
1,613
1,431
1,051
500
894
835
782
297
591
607
506
1,049
2,225
3,477
3,638
3,958
4,243
6,343
4,400
4,938
3,664
2,767
3,122
3,112
5,854
4,905
4,790
2,842
2,979
4,318
3,298
1,877
2,182
2,541
3,132
2,551
3,233
3,699
4,330
2,825
3,744
2,863
3,478
3,060
2,877
2,149
1,891
4,857
1,141
1,153
589
1,061
1,093
1,282
1,158
1,366
848
1,025
990
1,235
1,112
687
600
927
927
398
436
667
849
414
831
966
648
141
390
3901416489668314148496674363989279276006871,1121,2359901,0258481,3661,1581,2821,0931,0615891,1531,1414,8571,8912,1492,8773,0603,4782,8633,7442,8254,3303,6993,2332,5513,1322,5412,1821,8773,2984,3182,9792,8424,7904,9055,8543,1123,1222,7673,6644,9384,4006,3434,2433,9583,6383,4772,2251,0495066075912977828358945001,0511,4311,61302,16601329668684444190190192195200200394117
       Other Current Liabilities 
21
32
125
30
0
0
67
77
77
0
0
0
0
0
0
4
5,288
0
988
516
529
327
150
293
196
348
402
639
1,799
-691,140
1,325
1,276
1,853
2,748
1,868
-1,024,752,486
2,615
-1,208,983,911
3,396
4,298
4,497
4,950
5,442
5,505
5,433
5,078
3,123
3,334
2,679
2,991
2,896
2,828
2,863
3,026
3,041
3,135
3,013
3,208
3,180
3,140
3,247
3,997
3,800
3,778
4,236
1,355
4,490
4,232
4,885
5,010
4,475
4,369
5,253
5,822
5,986
6,086
5,821
2,926
2,981
3,384
1,961
2,183
1,895
2,007
1,994
2,795
2,285
2,359
2,112
0
1,378
1,480
1,362
1,3621,4801,37802,1122,3592,2852,7951,9942,0071,8952,1831,9613,3842,9812,9265,8216,0865,9865,8225,2534,3694,4755,0104,8854,2324,4901,3554,2363,7783,8003,9973,2473,1403,1803,2083,0133,1353,0413,0262,8632,8282,8962,9912,6793,3343,1235,0785,4335,5055,4424,9504,4974,2983,396-1,208,983,9112,615-1,024,752,4861,8682,7481,8531,2761,325-691,1401,79963940234819629315032752951698805,288400000077776700301253221
   > Long-term Liabilities 
483
491
553
319
319
49
49
127
127
44
44
68
68
96
0
0
31
0
31
31
32
32
32
33
33
34
36
36
36
36
37
37
37
37
8,047
10,162
8,417
1,006
329
73
8,703
129
143
157
171
96
110
136
6,675
12,661
13,177
13,211
11,609
11,656
11,732
11,790
9,743
11,790
11,403
10,915
9,522
9,213
9,181
9,502
7,579
7,654
7,654
7,571
5,134
5,127
5,376
5,079
2,935
2,952
2,884
3,426
1,712
1,710
1,652
1,225
875
6,119
5,800
5,533
740
755
765
805
2,184
2,194
2,170
2,141
2,177
2,1772,1412,1702,1942,1848057657557405,5335,8006,1198751,2251,6521,7101,7123,4262,8842,9522,9355,0795,3765,1275,1347,5717,6547,6547,5799,5029,1819,2139,52210,91511,40311,7909,74311,79011,73211,65611,60913,21113,17712,6616,675136110961711571431298,703733291,0068,41710,1628,047373737373636363634333332323231310310096686844441271274949319319553491483
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,518
12,484
12,983
12,997
0
1,629
1,637
1,642
3,148
1,541
1,551
1,505
1,499
1,440
1,440
8,854
6,876
6,916
7,165
6,799
4,369
4,363
4,470
4,218
2,121
2,150
2,117
0
0
0
852
325
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000003258520002,1172,1502,1214,2184,4704,3634,3696,7997,1656,9166,8768,8541,4401,4401,4991,5051,5511,5413,1481,6421,6371,629012,99712,98312,4846,518000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
33
33
34
35
36
37
37
37
37
37
37
1,965
1,158
728
934
257
0
0
0
0
0
0
0
0
0
0
176
0
0
0
2,516
3,179
2,537
2,431
708
534
346
173
572
607
648
703
738
791
772
765
764
783
765
743
753
742
742
772
806
800
814
810
824
828
783
740
0
0
0
0
0
0
0
0
000000007407838288248108148008067727427427537437657837647657727917387036486075721733465347082,4312,5373,1792,51600017600000000002579347281,1581,9653737373737373635343333320000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
73
115
129
143
0
0
0
0
136
156
176
194
214
0
2,516
3,179
2,537
2,431
708
535
346
172
572
607
648
703
738
791
772
765
764
783
765
743
753
742
742
772
806
800
814
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000008148008067727427427537437657837647657727917387036486075721723465357082,4312,5373,1792,5160214194176156136000014312911573000000000000000000000000000000000000000
> Total Stockholder Equity
-99
-185
-153
-566
-566
-645
-713
-734
-734
-44
-40
-68
-68
-96
-132
-4
4,130
0
13,377
15,212
17,105
20,850
27,238
30,999
34,655
39,761
45,697
60,098
64,483
69,868
73,633
77,925
85,174
90,396
97,336
103,189
110,509
117,937
124,221
131,040
135,919
142,483
146,213
148,164
149,335
148,517
146,524
144,279
142,857
132,944
129,439
120,950
114,655
106,254
98,766
95,000
86,814
72,641
71,569
66,961
64,935
58,909
58,422
57,143
57,031
43,071
43,071
41,025
37,633
30,199
30,617
28,968
27,357
9,238
8,380
8,399
7,859
8,005
7,166
6,525
6,855
6,018
5,340
4,025
2,835
4,290
4,669
4,353
6,111
7,455
8,292
7,409
6,528
6,5287,4098,2927,4556,1114,3534,6694,2902,8354,0255,3406,0186,8556,5257,1668,0057,8598,3998,3809,23827,35728,96830,61730,19937,63341,02543,07143,07157,03157,14358,42258,90964,93566,96171,56972,64186,81495,00098,766106,254114,655120,950129,439132,944142,857144,279146,524148,517149,335148,164146,213142,483135,919131,040124,221117,937110,509103,18997,33690,39685,17477,92573,63369,86864,48360,09845,69739,76134,65530,99927,23820,85017,10515,21213,37704,130-4-132-96-68-68-40-44-734-734-713-645-566-566-153-185-99
   Common Stock
6
6
7
7
7
7
7
0
0
1
1
1
1
1
1
3
28
0
35
35
35
35
37
37
37
37
37
42
42
42
42
42
42
42
43
43
43
43
43
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
46
46
46
47
47
48
49
50
75
85
87
105
0
15
17
18
1817150105878575504948474746464644444444444444444444444444444444444444444444444444444444444444444444444444444343434343424242424242423737373737353535350283111111007777766
   Retained Earnings 
-1,875
-1,975
-2,334
-2,809
-2,809
-2,912
-2,994
-3,035
-3,035
-3,740
-3,736
-3,834
-3,834
-3,862
-3,898
-5,677
620
0
5,418
7,201
8,908
12,387
14,761
18,087
21,172
25,206
29,397
33,434
37,685
43,040
46,717
51,004
58,167
63,273
67,568
72,844
78,329
85,017
90,121
95,190
98,482
104,287
107,093
108,853
110,148
108,904
106,092
101,628
99,326
88,896
86,506
77,863
71,535
62,849
54,875
50,760
46,611
33,940
32,387
29,933
28,183
24,757
23,790
21,503
19,307
5,480
5,480
4,178
2,322
-5,270
-5,688
-6,526
-7,227
-25,972
-26,633
-26,620
-27,630
-28,839
-29,607
-30,431
-31,258
-32,239
-33,268
-34,157
-34,947
-36,211
-36,687
-37,281
-38,058
-39,290
-40,246
-41,684
-42,802
-42,802-41,684-40,246-39,290-38,058-37,281-36,687-36,211-34,947-34,157-33,268-32,239-31,258-30,431-29,607-28,839-27,630-26,620-26,633-25,972-7,227-6,526-5,688-5,2702,3224,1785,4805,48019,30721,50323,79024,75728,18329,93332,38733,94046,61150,76054,87562,84971,53577,86386,50688,89699,326101,628106,092108,904110,148108,853107,093104,28798,48295,19090,12185,01778,32972,84467,56863,27358,16751,00446,71743,04037,68533,43429,39725,20621,17218,08714,76112,3878,9087,2015,4180620-5,677-3,898-3,862-3,834-3,834-3,736-3,740-3,035-3,035-2,994-2,912-2,809-2,809-2,334-1,975-1,875
   Accumulated Other Comprehensive Income 
-144
-165
-184
-204
3
27
42
7
7
2
2
2
2
2
2
0
-73
0
159
212
397
664
880
1,316
1,886
2,839
4,585
5,559
5,693
5,720
5,807
5,813
5,899
5,903
5,917
6,321
8,095
9,624
10,762
12,472
14,003
14,704
15,571
15,677
15,553
15,978
16,798
19,017
19,897
20,414
19,299
19,453
19,486
19,771
20,258
20,607
16,569
15,067
15,548
13,394
13,118
10,518
10,998
12,006
14,090
14,000
13,958
13,213
11,678
11,835
12,671
11,860
10,950
11,576
11,379
11,385
11,855
12,345
12,274
12,458
12,420
12,564
12,615
11,989
11,390
11,573
11,778
11,255
11,326
0
11,430
11,385
11,523
11,52311,38511,430011,32611,25511,77811,57311,39011,98912,61512,56412,42012,45812,27412,34511,85511,38511,37911,57610,95011,86012,67111,83511,67813,21313,95814,00014,09012,00610,99810,51813,11813,39415,54815,06716,56920,60720,25819,77119,48619,45319,29920,41419,89719,01716,79815,97815,55315,67715,57114,70414,00312,47210,7629,6248,0956,3215,9175,9035,8995,8135,8075,7205,6935,5594,5852,8391,8861,3168806643972121590-7302222227742273-204-184-165-144
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,334
23,391
23,449
23,505
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
24,453
24,453
24,453
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000024,45324,45324,45323,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,50523,44923,39123,334000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
1,915
1,948
2,359
2,439
2,232
2,232
2,232
2,294
2,294
3,693
3,693
3,763
3,763
3,763
3,763
5,670
3,482
0
7,765
7,765
7,765
7,765
11,560
11,560
11,560
11,679
11,679
21,063
21,063
21,066
21,066
21,066
21,066
21,178
23,808
23,981
24,042
23,252
23,294
23,334
23,391
23,449
23,505
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
13,958
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
24,453
24,453
24,453
25,645
25,645
25,944
26,143
26,342
28,854
29,494
30,291
32,738
0
37,093
37,691
37,790
37,79037,69137,093032,73830,29129,49428,85426,34226,14325,94425,64525,64524,45324,45324,45323,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59013,95823,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,59023,50523,44923,39123,33423,29423,25224,04223,98123,80821,17821,06621,06621,06621,06621,06321,06311,67911,67911,56011,56011,5607,7657,7657,7657,76503,4825,6703,7633,7633,7633,7633,6933,6932,2942,2942,2322,2322,2322,4392,3591,9481,915



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,011
Cost of Revenue-7,292
Gross Profit-281-281
 
Operating Income (+$)
Gross Profit-281
Operating Expense-2,471
Operating Income-2,752-2,752
 
Operating Expense (+$)
Research Development240
Selling General Administrative1,466
Selling And Marketing Expenses780
Operating Expense2,4712,486
 
Net Interest Income (+$)
Interest Income5
Interest Expense-334
Other Finance Cost-46
Net Interest Income-374
 
Pretax Income (+$)
Operating Income-2,752
Net Interest Income-374
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,079-2,425
EBIT - interestExpense = -3,079
-3,079
-2,745
Interest Expense334
Earnings Before Interest and Taxes (EBIT)-2,745-2,745
Earnings Before Interest and Taxes (EBITDA)8
 
After tax Income (+$)
Income Before Tax-3,079
Tax Provision-0
Net Income From Continuing Ops-3,111-3,079
Net Income-3,079
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses9,763
Total Other Income/Expenses Net-327374
 

Technical Analysis of China Pharma Holdings Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of China Pharma Holdings Inc. The general trend of China Pharma Holdings Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine China Pharma Holdings Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of China Pharma Holdings Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.18 < 0.18 < 0.2035.

The bearish price targets are: 0.0892.

Tweet this
China Pharma Holdings Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of China Pharma Holdings Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

China Pharma Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of China Pharma Holdings Inc. The current macd is -0.01076331.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the China Pharma Holdings Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for China Pharma Holdings Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the China Pharma Holdings Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
China Pharma Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartChina Pharma Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of China Pharma Holdings Inc. The current adx is 36.22.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell China Pharma Holdings Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
China Pharma Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of China Pharma Holdings Inc. The current sar is 0.2.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
China Pharma Holdings Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of China Pharma Holdings Inc. The current rsi is 42.53. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
China Pharma Holdings Inc Daily Relative Strength Index (RSI) ChartChina Pharma Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of China Pharma Holdings Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the China Pharma Holdings Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
China Pharma Holdings Inc Daily Stochastic Oscillator ChartChina Pharma Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of China Pharma Holdings Inc. The current cci is -149.38320038.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
China Pharma Holdings Inc Daily Commodity Channel Index (CCI) ChartChina Pharma Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of China Pharma Holdings Inc. The current cmo is -13.60377244.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
China Pharma Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartChina Pharma Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of China Pharma Holdings Inc. The current willr is -45.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that China Pharma Holdings Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
China Pharma Holdings Inc Daily Williams %R ChartChina Pharma Holdings Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of China Pharma Holdings Inc.

China Pharma Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of China Pharma Holdings Inc. The current atr is 0.02452234.

China Pharma Holdings Inc Daily Average True Range (ATR) ChartChina Pharma Holdings Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of China Pharma Holdings Inc. The current obv is 19,708,915.

China Pharma Holdings Inc Daily On-Balance Volume (OBV) ChartChina Pharma Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of China Pharma Holdings Inc. The current mfi is 45.93.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
China Pharma Holdings Inc Daily Money Flow Index (MFI) ChartChina Pharma Holdings Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for China Pharma Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

China Pharma Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of China Pharma Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.535
Ma 20Greater thanMa 500.191
Ma 50Greater thanMa 1000.213
Ma 100Greater thanMa 2000.212
OpenGreater thanClose0.174
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of China Pharma Holdings Inc with someone you think should read this too:
  • Are you bullish or bearish on China Pharma Holdings Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about China Pharma Holdings Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about China Pharma Holdings Inc

I send you an email if I find something interesting about China Pharma Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about China Pharma Holdings Inc.

Receive notifications about China Pharma Holdings Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.